Therapeutic activation of AMPK for the aging right heart
Therapeutic activation of AMPK for the aging right heart
批准号:
10555925
负责人:
Danielle Reuland Bruns
金额:
$14.45万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-03-01 至 2023-11-30
关键词:
5&apos-AMP-activated protein kinaseAddressAdministrative SupplementAgeAgingAttenuatedAwardBiochemicalBiologicalBiology of AgingCardiacClinicalDataDiseaseElderlyFemaleGoalsGrantHealth SciencesHeartHeart failureHypoglycemic AgentsLeftLife Cycle StagesLinkLung diseasesMechanicsMediatingMetforminMicrofilamentsModelingMorbidity - disease rateMusMuscle CellsOutcomeParentsPathogenesisPathway interactionsPatientsPharmacologyPhysiologic intraventricular pressurePlant RootsPopulationPre-Clinical ModelProtein KinasePublic HealthPulmonary HypertensionResearchRight Ventricular DysfunctionRight Ventricular FunctionSample SizeSex DifferencesSideSignal PathwaySignal TransductionTestingTherapeuticTherapeutic InterventionTrainingVentricularWomen&aposs HealthWomen&aposs RightsWorkage differenceage relatedagedaging populationbasebiological sexclinically relevantcomorbidityexperienceexperimental studyheart functionimprovedin vivointerestlung hypoxiamalemortalitynovelnovel therapeuticspre-clinicalprogramsresponseright ventricular remodelingsexsurvival predictiontherapy outcometreatment response
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
The overarching goal of this application is to understand sex differences right ventricular (RV) function and how
these differences change across the life-course. Dr. Bruns is a current K01 awardee (K01 AG058819) with
growing expertise in cardiac aging and a strong interest in how sex differences contribute to cardiac aging. In
age-related left-sided heart failure as well as other clinical contexts, right ventricular (RV) dysfunction is the
strongest predictor of mortality. However, despite the clear link between right heart function and survival, very
little is known about RV function with age and no RV-directed therapies exist. Through ongoing work as part of
the parent K01, we have identified preliminary sex differences in RV pathogenesis and in the RV response to
therapeutic interventions. However, the parent award is underpowered to mechanistically understand the
differences in male and female RV function and how it changes with advanced age. Therefore, the aim of this
supplement is to mechanistically investigate RV sex differences using a translationally relevant pre-clinical
model of RV-centric disease. We will assess myofilament-mediated mechanisms of age- and sex differences
in RV function- a primary focus of the training and scientific training of the parent award. Therefore, the
experiments we propose are well within the scope of the parent award. We will achieve this goal by increasing
sample sizes to increase power to statistically analyze sex differences. The outcomes achieved by this
supplement will advance the ORWH strategic goal of promoting rigorous research that improves fundamental
understanding of how sex influences the aging RV and RV disease.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1371/journal.pone.0245055
发表时间:
2021
期刊:
PloS one
影响因子:
3.7
作者:
[Stephens KE, Chernyavskiy P, Bruns DR]
通讯作者:
Bruns DR
Age- and sex-specific differences in activation of the cardiac adrenergic cascade.
心脏肾上腺素级联激活的年龄和性别特异性差异。
DOI:
--
发表时间:
2022
期刊:
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
影响因子:
--
作者:
[Yusifov,Aykhan, Borders,MeganO, Woulfe,KathleenC, Bruns,DanielleR]
通讯作者:
Bruns,DanielleR
Therapeutic activation of AMPK for the aging right heart
-
批准号:10063932
-
项目类别:
-
资助金额:$13.21万
-
财政年份:2019
-
负责人:Danielle Reuland Bruns
-
依托单位:
Therapeutic activation of AMPK for the aging right heart
-
批准号:10321586
-
项目类别:
-
资助金额:$13.21万
-
财政年份:2019
-
负责人:Danielle Reuland Bruns
-
依托单位:
Therapeutic activation of AMPK for the aging right heart
-
批准号:10530620
-
项目类别:
-
资助金额:$13.21万
-
财政年份:2019
-
负责人:Danielle Reuland Bruns
-
依托单位:
海外基金